Investigating miR-375-mediated regulation of intestinal helminth infection
研究 miR-375 介导的肠道蠕虫感染调节
基本信息
- 批准号:10371515
- 负责人:
- 金额:$ 21.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAgeArchitectureBindingBinding SitesBioinformaticsBiological AssayBone MarrowCRISPR/Cas technologyCell CountCell Differentiation processCell LineageCell MaturationCellsDataDevelopmentEpithelialEpithelial CellsExhibitsFollow-Up StudiesFoundationsFutureGene ExpressionGenesGeneticGenetic studyGoalsHelminthsHookworm InfectionsHumanImmuneImmune responseIndividualInfectionInfection preventionInterleukin-13IntestinesKnock-outKnockout MiceKnowledgeLoxP-flanked alleleLuciferasesMeasuresMediatingMicroRNAsModelingMolecularMorbidity - disease rateMusNematospiroides dubiusParasitesPathway interactionsPublic HealthRegulationResistanceRoleSecretory CellSignal TransductionSmall IntestinesSoilTestingTherapeuticTissuesTransgenic MiceVillusWild Type Mousebasecell typegastrointestinal epitheliumhelminth infectionimprovedin vivointestinal cryptintestinal epitheliumnovelprotective effectresponsesexsingle-cell RNA sequencingstemstem cellstissue repairtranscription factortranscriptomicsvillin
项目摘要
PROJECT SUMMARY: Soil-transmitted intestinal helminth parasites infect billions of people worldwide, causing
substantial morbidity and posing a significant global public health problem. Recent hallmark studies have shown
that following helminth infection, specialized cells in the gut epithelium called tuft cells expand and trigger a host-
protective type 2 immune response that promotes parasite expulsion and tissue repair. Tuft cells are derived
from stem cells at the base of the intestinal epithelial crypt, and transcription factors such as Pou2f3 that drive
the maturation of tuft cells have been identified. However, despite these advances, the molecular mechanisms
that control tuft cell abundance and anti-helminth function remain incompletely understood. Although it is
established that microRNAs (miRNAs) as a class of regulatory molecules are critical for proper intestinal
architecture and function, the roles of individual miRNAs in the intestinal epithelium are just now starting to
emerge. We recently discovered that the whole-body genetic deletion of a single miRNA, miR-375, was
associated with lower worm burdens after infection with Heligmosomoides polygyrus, a helminth parasite of mice
used as a model for human hookworm infection. Moreover, the 375-/- mice exhibited increased abundance of
tuft cells in the small intestine. Notably, we also determined through a bioinformatic screen that Pou2f3 is a
predicted target of miR-375. This proposal is focused on bridging two critical knowledge gaps: (1) Is the effect
on H. polygyrus worm burden mediated by loss of miR-375 function in the intestinal epithelial cell (IEC) lineage,
immune cell lineage, or both? and (2) Does the effect of miR-375 loss depend on Pou2f3-mediated maturation
of tuft cells? In the first Aim, we will define the impact of IEC-specific miR-375 loss on resistance to H. polygyrus.
To accomplish this goal, we will apply two independent, complementary strategies. Specifically, we will: (i)
generate bone marrow chimeric mice, in which miR-375 deficiency is restricted to non-immune cells, and also
(ii) breed miR-375fl/fl;Vil1-Cre mice, in which miR-375 deficiency is specific to IECs, and compare H. polygyrus
worm burden after infection with what we have observed previously in whole-body miR-375-/- mice. In the second
Aim, we will establish whether tuft cells are required for the effects of miR-375 loss on H. polygyrus worm burden.
We will first determine whether Pou2f3 is a direct target of miR-375 and also leverage single cell transcriptomics
to identify additional candidate miR-375 target genes whose expression levels are significantly increased in
intestinal epithelial stem and/or secretory progenitor cells of 375-/- mice during the response to helminth
infection. We will then perform genetic studies to determine whether loss of Pou2f3 is sufficient to negate the
positive effects of miR-375 loss on H. polygyrus worm burden. The completion of these studies will substantially
advance the field by establishing that an IEC miRNA regulates tuft cell-mediated anti-helminth function during
H. polygyrus infection. Improved understanding of the key epithelial regulators of the host response to helminth
will be critical for developing new strategies to treat and prevent infection.
项目摘要:土壤传播的肠道蠕虫寄生虫感染了全球数十亿人
大量的发病率并带来了重大的全球公共卫生问题。最近的Hallmark研究表明
在蠕虫感染后,肠道上皮中的专门细胞称为簇细胞扩张并触发宿主 -
保护性2型免疫反应,可促进寄生虫驱动和组织修复。簇细胞得出
从肠上皮隐窝底部的干细胞以及驱动诸如POU2F3之类的转录因子
已经鉴定出簇细胞的成熟。但是,尽管有这些进步,分子机制
控制簇细胞丰度和抗螺旋功能仍然不完全理解。虽然是
确定microRNA(miRNA)作为一类调节分子对于适当的肠道至关重要
建筑和功能,单个miRNA在肠上皮中的作用刚刚开始
出现。我们最近发现,单个miRNA的全身遗传缺失,miR-375是
与Heligmosomoides Polygyrus感染后,蠕虫寄生虫是小鼠寄生虫,与较低的蠕虫负担相关
用作人钩虫感染的模型。此外,375 - / - 小鼠的丰度增加
小肠中的簇细胞。值得注意的是,我们还通过生物信息学屏幕确定了POU2F3是一个
预测miR-375的靶标。该建议的重点是弥合两个关键的知识差距:(1)效果是
在肠道上皮细胞(IEC)谱系中miR-375功能的损失介导的多孔猪螺旋体负担上,
免疫细胞谱系,还是两者兼而有之? (2)miR-375损失的影响取决于POU2F3介导的成熟
簇细胞?在第一个目的中,我们将定义IEC特异性miR-375损失对抗多犬H. polygyrus的影响。
为了实现这一目标,我们将采用两种独立的互补策略。具体来说,我们将:(i)
产生骨髓嵌合小鼠,其中miR-375缺乏仅限于非免疫细胞,也是
(ii)mir-375fl/fl; vil1-cre小鼠,其中miR-375缺乏特定于IEC,并比较polygyrus H. polygyrus
感染后我们先前在全身miR-375 - / - 小鼠中观察到的蠕虫负担。在第二个
目的,我们将确定miR-375损失对h. polygyrus蠕虫负担的影响是否需要簇状细胞。
我们将首先确定POU2F3是否是miR-375的直接靶标,并且还利用单细胞转录组学
确定其他候选miR-375靶基因,其表达水平在
在对蠕虫的反应期间,375 - / - 小鼠的肠上皮茎和/或分泌祖细胞
感染。然后,我们将进行遗传研究,以确定POU2F3的丢失是否足以消除
miR-375损失对h. polygyrus蠕虫负担的积极影响。这些研究的完成将大大
通过确定IEC miRNA调节簇细胞介导的抗螺旋功能,以推进该领域
H. Polygyrus感染。对主机对蠕虫的反应的关键上皮调节器的理解得以提高
对于制定新的策略来治疗和防止感染至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Praveen Sethupathy其他文献
Praveen Sethupathy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Praveen Sethupathy', 18)}}的其他基金
Discovery of aberrant enhancer activities during gut development that underlie genetic predisposition to pediatric Crohn's disease
肠道发育过程中异常增强子活性的发现是儿童克罗恩病遗传易感性的基础
- 批准号:
10372239 - 财政年份:2021
- 资助金额:
$ 21.57万 - 项目类别:
Investigating miR-375-mediated regulation of intestinal helminth infection
研究 miR-375 介导的肠道蠕虫感染调节
- 批准号:
10495270 - 财政年份:2021
- 资助金额:
$ 21.57万 - 项目类别:
Discovery of aberrant enhancer activities during gut development that underlie genetic predisposition to pediatric Crohn's disease
肠道发育过程中异常增强子活性的发现是儿童克罗恩病遗传易感性的基础
- 批准号:
10494257 - 财政年份:2021
- 资助金额:
$ 21.57万 - 项目类别:
Project 1: Molecular Drivers of Arsenic- Induced Diabetes
项目1:砷诱发糖尿病的分子驱动因素
- 批准号:
10570864 - 财政年份:2020
- 资助金额:
$ 21.57万 - 项目类别:
Discovery of microRNA regulatory modules controlling human pancreatic islet funct
发现控制人胰岛功能的 microRNA 调节模块
- 批准号:
8475587 - 财政年份:2012
- 资助金额:
$ 21.57万 - 项目类别:
Discovery of microRNA regulatory modules controlling human pancreatic islet funct
发现控制人胰岛功能的 microRNA 调节模块
- 批准号:
8416637 - 财政年份:2012
- 资助金额:
$ 21.57万 - 项目类别:
Discovery of microRNA regulatory modules controlling human pancreatic islet funct
发现控制人胰岛功能的 microRNA 调节模块
- 批准号:
8666746 - 财政年份:2012
- 资助金额:
$ 21.57万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 21.57万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 21.57万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 21.57万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 21.57万 - 项目类别: